Xeltis Receives CE Mark for aXess Hemodialysis Conduit

Xeltis has received the CE mark for its aXess hemodialysis conduit, marking its transition from clinical to commercial stage. The CE mark was granted in just 84 working days, allowing Xeltis to market its innovative product across Europe, which aims to improve vascular access for hemodialysis patients. This approval signifies a major milestone in Xeltis’ development and the potential for enhanced patient care in treating kidney disease.